To qualify for this study, participants must:
Be 55 or older with one or more:
-
- Coronary Artery Disease
- Peripheral arterial disease (PAD)
- Known familial hypercholesterolemia (either by diagnosis or LDL ≥ 100 mg/dL while on lipid-lowering medication
OR
- Are you 55 years or older with three or more of the following:
- 65 or older for Males
- 70 or older for Females
- Current tobacco use
- High blood pressure
- Kidney disease
- Diabetes
- Family history of premature cardiovascular events (heart attack or coronary bypass surgery in father or brother younger than 55; heart attack or coronary bypass surgery in mother or sister younger than 60)
- Coronary Artery Calcium (CAC) score
- ≥300 for anyone
- ≥100 for individuals assigned female at birth < 65 years of age
- High cholesterol
AND
- Not have had a heart attack or stroke
- Not have had coronary or peripheral revascularization in the past 3 months
- Not have received a coronary artery score of 0 in the past 5 years
- Not have had cancer in the past 5 years ( except skin, cervix, or prostate cancer)
- Not have any active infection or major diseases
- Not be pregnant or breastfeeding
- Not have taken any of the following medications for lowering Lp(a):
- Lepodisiran
- Muvalaplin
- Pelacarsen
- Olpasiran
- Zerlasiran
- Obicetrapib
- Be on stable lipid-lowering medications in the past month, if on lipid-lowering medication
- Be on a stable PCSK inhibitor in the past 2 months, if on a PCSK inhibitor
- Be willing to take a highly effective form of birth control
- Additional criteria will apply
PLEASE NOTE: Please confirm your eligibility before your appointment by calling 210-714-0067
If you do not see an available appointment, please call 210-714-0067 for availability.
Transportation may be available. Call 210-714-0067. Compensation up to $1,680 is available for time and travel.
By signing up you agree to receive text messages and emails about this and similar studies near you. You can unsubscribe at any time. Text messages and data rates may apply.
Schedule Appointment